Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.00 is 100% below its 1-year average of 0.02, near the low end of its 1-year range (0.00–0.05).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00.
DEBT TO EQUITY RATIO
0.00
DEBT TO EQUITY RATIO AVG TTM
N/A
DEBT TO EQUITY RATIO AVG 3Y
N/A
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.14
median of 470 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$9.70M
Debt to Equity Ratio
0.19
TTM Avg
0.16
3Y Avg
0.12
5Y Avg
0.10
Market Cap
$8.94M
Debt to Equity Ratio
0.00
TTM Avg
0.05
3Y Avg
0.05
5Y Avg
0.05
Market Cap
$10.38M
Debt to Equity Ratio
0.01
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$10.83M
Debt to Equity Ratio
0.09
TTM Avg
0.06
3Y Avg
1.84
5Y Avg
2.48
Market Cap
$9.18M
Debt to Equity Ratio
0.08
TTM Avg
0.22
3Y Avg
0.19
5Y Avg
0.16
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caring Brands, Inc. (CABR) | $10.55M | 0.00 | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.89M | 4.21 | 1.11 | 0.63 | 0.57 |
| Lifeward Ltd. (LFWD)vs › | $9.92M | 0.91 | 0.29 | 0.15 | 0.12 |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.70M | 0.19 | 0.16 | 0.12 | 0.10 |
| SeaStar Medical Holding Corporation (ICU)vs › | $8.94M | 0.00 | 0.05 | 0.05 | 0.05 |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $10.38M | 0.01 | 0.00 | 0.00 | 0.00 |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.83M | 0.09 | 0.06 | 1.84 | 2.48 |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.18M | 0.08 | 0.22 | 0.19 | 0.16 |
| BioVie Inc. (BIVI)vs › | $11.09M | 0.03 | 0.03 | 0.35 | 0.79 |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.21M | 0.02 | 0.01 | 0.01 | 0.02 |
Debt/Equity
0.00
Current Ratio
4.96
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.00 |
| 2026-03-31 | 0.00 |
| 2025-12-31 | 0.03 |
| 2025-09-30 | 0.05 |
